Top 10 Casino Stocks To Watch For 2019

Michael E. Lewitt

Back in April, I recommended Caesars Entertainment Corp. (Nasdaq: CZR) as a buy – but warned you that this was a play that might take some time to mature.

If you haven’t gotten in already, you’ll want to do it soon.

After months of bitter wrangling, the much-beleaguered Caesars has finally reached a $5 billion deal with the private-equity sponsors that looted the company, Apollo Global Management, LLC (NYSE: APO) and TPG Capital (formerly Texas Pacific Group). Pending approval by the U.S. Bankruptcy Court in Chicago, CZR is now set to leave bankruptcy, get rid of its debt, and get back on its feet.

Of course, this means very good news for stockholders (like you, I hope).

Here’s why you can expect to start seeing profits…

CZR’s Bonds Are Recovering – and Its Stock Will, Too

The sad chapter of Caesars Entertainment’s ownership by these two private-equity firms appears to be mercifully coming to an end. The firms agreed to increase their offer to repay the creditors some (but not all) of the billions of dollars they looted from the company in a desperate and disgusting effort to save their ill-fated investment in the casino giant. While they will retain an equity interest in the company, a majority of the stock will be held by the creditors who suffered at their hands.

Top 10 Casino Stocks To Watch For 2019: Telefonica Brasil S.A.(VIV)

Advisors’ Opinion:

  • [By Paul Ausick]

    Telefônica Brasil SA (NYSE: VIV) dropped about 2.3% Wednesday to set a new 52-week low of $9.72. Shares closed at $9.95 on Tuesday and the stock’s 52-week high is $17.33. Volume totaled around 1.4 million, about 25% below the daily average. The company had no specific news.

  • [By Ethan Ryder]

    Windstream (NASDAQ: WIN) and Telefonica Brasil (NYSE:VIV) are both computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk and institutional ownership.

  • [By Max Byerly]

    Vivendi (EPA:VIV) received a €23.50 ($27.33) price target from stock analysts at Barclays in a research note issued on Friday. The brokerage currently has a “neutral” rating on the stock.

  • [By Ethan Ryder]

    UBS Group set a €25.50 ($29.65) target price on Vivendi (EPA:VIV) in a research note issued to investors on Friday morning, www.boersen-zeitung.de reports. The brokerage currently has a buy rating on the stock.

Top 10 Casino Stocks To Watch For 2019: Enduro Royalty Trust(NDRO)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Enduro Royalty Trust (NDRO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Enduro Royalty Trust (NDRO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Jounce Therapeutics, Inc. (NASDAQ: JNCE) fell 32.5 percent to $11.92 in pre-market trading. Jounce Therapeutics reported that data from ongoing ICONIC trial of JTX-2011 will be presented at the ASCO.
    Acxiom Corporation (NASDAQ: ACXM) fell 10.7 percent to $24.60 in pre-market trading. Acxiom reported stronger-than-expected results for its fourth quarter, but issued weak FY19 guidance.
    American Public Education, Inc. (NASDAQ: APEI) shares fell 10.7 percent to $35 in pre-market trading.
    Enduro Royalty Trust (NYSE: NDRO) shares fell 8.5 percent to $3.25 in pre-market trading after tumbling 10.76 percent on Wednesday.
    NetEase, Inc. (NASDAQ: NTES) fell 8.3 percent to $244.00 in pre-market trading after reporting Q1 results.
    Aircastle Limited (NYSE: AYR) fell 7.2 percent to $21.30 in pre-market trading after announcing 7.9 million secondary offering of common shares.
    Boxlight Corporation (NASDAQ: BOXL) shares fell 5.6 percent to $9.29 in pre-market trading after rising 2.29percent on Wednesday.
    Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) shares fell 5.3 percent to $3.93 in pre-market trading after rising 5.60 percent on Wednesday.
    Cisco Systems, Inc. (NASDAQ: CSCO) fell 4 percent to $43.40 in pre-market trading. Cisco reported better-than-expected results for its third quarter. The company sees fourth quarter earnings in the range of 68 cents-70 cents with sales growth of 4-6 percent.
    Jack in the Box Inc. (NASDAQ: JACK) fell 3.2 percent to $88.45 in pre-market trading after the company reported downbeat results for its second quarter. Comps were down 0.1 percent in the quarter. The company sees third-quarter comps coming in flat to up 1 percent.
    Children's Place, Inc. (

Top 10 Casino Stocks To Watch For 2019: VistaGen Therapeutics, Inc. (VTGN)

Advisors’ Opinion:

  • [By Max Byerly]

    These are some of the media stories that may have effected Accern Sentiment Analysis’s scoring:

    Get Vistagen Therapeutics alerts:

    Investor’s Alert (Earnings Per Share) – VistaGen Therapeutics Inc (NASDAQ: VTGN) (stocksmarketcap.com) Stock Technical’s & Performances to Explore – VistaGen Therapeutics Inc (NASDAQ: VTGN) (stockspen.com) US STOCKS ON THE MOVE-Media and telecom stocks, H & R Block, TAL Education (nasdaq.com) Tracking the HMA Level on These Shares: VistaGen Therapeutics, Inc. (:VTGN): HMA Reading 1.4214792 (stocknewscaller.com) Keep Your Eyes on Hot Stock of Yesterday— VistaGen Therapeutics, Inc. (VTGN) (stockmarketstop.com)

    Vistagen Therapeutics traded down $0.02, reaching $1.46, on Tuesday, according to MarketBeat Ratings. The company’s stock had a trading volume of 2,930 shares, compared to its average volume of 2,201,613. The stock has a market cap of $34.35 million, a P/E ratio of -0.95 and a beta of 0.29. Vistagen Therapeutics has a 52 week low of $0.69 and a 52 week high of $2.65.

  • [By Ethan Ryder]

    Vistagen Therapeutics (NASDAQ:VTGN) was given a $6.00 price target by analysts at Oppenheimer Holdings Inc.. The firm currently has a buy rating on the stock.

  • [By Money Morning News Team]

    While exciting, CODX and our other penny stocks to watch this week are unlikely to tack on any additional gains this week. But don’t worry. After looking at our 10 top penny stocks to watch, we’ll show you a stock with serious profit potential in its future…

    Penny Stock Current Share Price Last Week’s Gain
    Co-Diagnostics Inc. (Nasdaq: CODX)  $4.35 192.07%
    Viking Therapeutics Inc. (Nasdaq: VKTX)  $9.37 95.78%
    DHI Group Inc. (NYSE: DHX)  $3.10 67.57%
    Axovant Sciences Ltd. (Nasdaq: AXON)  $1.76 60.00%
    Netlist Inc. (Nasdaq: NLST)  $0.21 53.79%
    Link Motion Inc. (NYSE LKM)  $1.23 47.73%
    CorMedix Inc. (NYSE: CRMD)  $0.26 44.44%
    Vistagen Therapeutics Inc. (Nasdaq: VTGN)  $1.34 40.21%
    J. Jill Inc. (NYSE: JILL)  $8.30 36.55%
    Adomani Inc. (Nasdaq: ADOM)  $1.52 34.86%

    In order to make sure we protect ourselves from any substantial losses from investing in penny stocks, we follow five rules for penny stock investing. Take look at them on the right.As these stocks demonstrate, there are penny stocks that have tremendous growth potential that can easily dwarf your initial investment. However, most penny stocks lack the solid underlying financials necessary to generate a significant return.
    Fast Money: This powerful secret made one man a millionaire. Now he’s sharing it live on camera – find out how you could use it to become $2,918 richer in less than a minute. Click here…

Top 10 Casino Stocks To Watch For 2019: CST Brands, Inc.(CST)

Advisors’ Opinion:

  • [By Shane Hupp]

    Cryptosolartech (CURRENCY:CST) traded up 4.2% against the dollar during the 1-day period ending at 20:00 PM ET on October 6th. One Cryptosolartech token can now be purchased for approximately $0.0203 or 0.00000309 BTC on exchanges. Cryptosolartech has a total market capitalization of $1.30 million and approximately $247,044.00 worth of Cryptosolartech was traded on exchanges in the last 24 hours. During the last seven days, Cryptosolartech has traded 4.1% lower against the dollar.

Top 10 Casino Stocks To Watch For 2019: Gold Standard Ventures Corporation(GSV)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Gold Standard Ventures Corp (NYSEAMERICAN:GSV) was the recipient of a significant drop in short interest during the month of May. As of May 15th, there was short interest totalling 6,511,796 shares, a drop of 7.7% from the April 30th total of 7,056,069 shares. Based on an average daily volume of 268,131 shares, the short-interest ratio is currently 24.3 days. Approximately 5.9% of the company’s stock are sold short.

Top 10 Casino Stocks To Watch For 2019: Templeton Dragon Fund Inc.(TDF)

Advisors’ Opinion:

  • [By Logan Wallace]

    News articles about Templeton Dragon Fund Inc common stock (NYSE:TDF) have trended somewhat positive on Sunday, Accern reports. The research firm identifies positive and negative media coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Templeton Dragon Fund Inc common stock earned a media sentiment score of 0.11 on Accern’s scale. Accern also gave news headlines about the financial services provider an impact score of 45.9946586007156 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

  • [By Shane Hupp]

    Templeton Dragon Fund Inc common stock (NYSE:TDF) major shareholder City Of London Investment Grou bought 8,155 shares of the company’s stock in a transaction that occurred on Tuesday, June 12th. The shares were purchased at an average price of $22.87 per share, with a total value of $186,504.85. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Major shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

Top 10 Casino Stocks To Watch For 2019: Applied Materials, Inc.(AMAT)

Advisors’ Opinion:

  • [By Paul Ausick]

    Applied Materials Inc. (NASDAQ: AMAT) dropped about 5.3% Thursday to set a new 52-week low of $40.25. Shares closed at $42.50 on Wednesday and the stock’s 52-week high is $62.40. Volume totaled around 19million, about 40% below the daily average. The semiconductor equipment maker is turning into an over-priced house in a declining neighborhood.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Applied Materials (AMAT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Chris Lange]

    Short interest in Applied Materials Inc. (NASDAQ: AMAT) decreased to 13.87 million shares. The previous reading was 16.51 million. Shares were trading at $39.19, in a 52-week range of $28.79 to $62.40.

  • [By Nicholas Rossolillo]

    That could cause anxiety, but it also spells opportunity for investors looking for a deal. Even the high-flying tech sector sports some real bargains these days. Three worth your consideration are Applied Materials (NASDAQ:AMAT), Micron Technology (NASDAQ:MU), and Vodafone (NASDAQ:VOD).

  • [By Ashraf Eassa]

    Although TSMC is an obvious beneficiary from the production of the A12 chip, there’s another company that’s poised to profit handsomely as Apple and other companies start building chips using TSMC’s (as well as other companies’) 7nm technologies: Applied Materials (NASDAQ:AMAT).

  • [By Jon C. Ogg]

    Applied Materials Inc. (NASDAQ: AMAT) typically has beaten its earnings and sales expectations. Apparently, the top U.S. player for semiconductor capital equipment is finding out that 29% in quarterly revenue growth (to $4.57 billion) and a 54% jump in operating income (to $1.22 per share) from a year ago aren’t enough in the face of expectations ahead.

Top 10 Casino Stocks To Watch For 2019: Xerium Technologies Inc.(XRM)

Advisors’ Opinion:

  • [By Shane Hupp]

    Media coverage about Xerium Technologies (NYSE:XRM) has trended somewhat positive this week, according to Accern Sentiment. Accern scores the sentiment of media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Xerium Technologies earned a news impact score of 0.17 on Accern’s scale. Accern also assigned press coverage about the industrial products company an impact score of 47.7306467260184 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Top 10 Casino Stocks To Watch For 2019: GlaxoSmithKline PLC(GSK)

Advisors’ Opinion:

  • [By Ethan Ryder]

    GlaxoSmithKline plc (NYSE:GSK) was the target of a large drop in short interest during the month of May. As of May 31st, there was short interest totalling 8,497,397 shares, a drop of 27.2% from the May 15th total of 11,675,520 shares. Based on an average daily volume of 2,406,543 shares, the short-interest ratio is currently 3.5 days.

  • [By Shane Hupp]

    Dean Capital Investments Management LLC acquired a new stake in GlaxoSmithKline plc (NYSE:GSK) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 20,362 shares of the pharmaceutical company’s stock, valued at approximately $821,000. GlaxoSmithKline comprises about 0.5% of Dean Capital Investments Management LLC’s portfolio, making the stock its 15th largest position.

  • [By Todd Campbell]

    Following the sharp sell-off in Sangamo’s shares, Lanphier agreed to step down as Sangamo’s CEO in June 2016. In his place, Sangamo’s board of directors hired Sandy Macrae, a GlaxoSmithKline (NYSE:GSK) veteran who had most recently been the global medical officer for Takeda Pharmaceuticals.

  • [By Chris Lange]

    GlaxoSmithKline PLC (NYSE: GSK) has a meeting with the FDA’s Pulmonary-Allergy Drugs Advisory Committee scheduled for July 25. The meeting is in regards to the firm’s supplementary Biologics License Agreement (sBLA) for its chronic obstructive pulmonary disease (COPD) treatment, mepolizumab.

  • [By George Budwell]

    As the company didn’t release any major clinical or regulatory news last month, Agenus’ shares appear to have gotten a boost mainly from the stronger-than-expected launch of GlaxoSmithKline’s (NYSE:GSK) shingles vaccine Shingrix.

Top 10 Casino Stocks To Watch For 2019: LightInTheBox Holding Co., Ltd.(LITB)

Advisors’ Opinion:

  • [By Logan Wallace]

    News stories about Lightinthebox (NYSE:LITB) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Lightinthebox earned a daily sentiment score of 0.04 on Accern’s scale. Accern also gave news headlines about the technology company an impact score of 46.3507616645709 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

Leave a Reply

Your email address will not be published. Required fields are marked *